洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2400082766】Implementation of an integrated Self-Care Health Service Ecosystem

基本信息
登记号

ChiCTR2400082766

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-04-07

临床申请受理号

/

靶点

/

适应症

None

试验通俗题目

Implementation of an integrated Self-Care Health Service Ecosystem

试验专业题目

Development and implementation of an integrated Self-Care Health Service Ecosystem

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

This seed project will serve as the first phase of the development and implementation of the self-care health service ecosystem. During the first phase, we will mainly focus on the conceptualization and planning, and creation of prototype of SHE. Thus, this project aims to: 1) To identify the core features of the app and prioritize them to create the Minimum Viable Product; 2) To create wireframes and prototype to visualize the app’s layout, user flow, and interactions (prototype creation); 3) To understand users’ experience on the use of HPV self-sampling and Dried Blood Spot (DBS) in general population (experience test); 4) To validate the risk algorithms for disease prevention and health problem alert; and 5) To explore the health information that the users are in need and can be used to train the chatbot (needs exploration).

试验分类
试验类型

横断面

试验分期

其它

随机化

N/A

盲法

None

试验项目经费来源

Innovation and Technology Fund

试验范围

/

目标入组人数

192

实际入组人数

/

第一例入组时间

2023-12-01

试验终止时间

2025-12-01

是否属于一致性

/

入选标准

1) HK resident; 2) Aged 18 or above; and 3) Able to read, understand and speaking Cantonese or English.;

排除标准

1) Current pregnancy at the time of recruitment; 2) Had total hysterectomy; 3) Have been diagnosed with an immunocompromised condition (e.g. Systemic Lupus Erythematosus, or illness with steroid-dependent); or 4) Have been diagnosed with any gynecologic cancers (e.g. cervical, ovarian, vaginal, uterine, vulvar, or breast cancer).;

研究者信息
研究负责人姓名
试验机构

The Chinese University of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

The Chinese University of Hong Kong的其他临床试验

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品